JFL Life Sciences was incorporated on April 25, 2010. The company is engaged in the business of manufacturing of pharmaceutical products. The product portfolio consists of dry powder injections, tablets and capsules (solid oral dosage form) and oral rehydration solutions.
| Bidding Dates |
|---|
| 25 Aug 2022 - 30 Aug 2022 |
| Subscription |
|---|
| 8.93x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹1,22,000 | 1 | 1 | 2000 | 3.0 M | ₹61 | 72.92 % | ₹181.7 M | RHP DOC |
JFL Life Sciences IPO SUBSCRIPTION STATUS
30 Aug '22JFL Life Sciences IPO overall subscription rate was 8.93 times the total available shares
JFL Life Sciences IPO retail subscription rate was 11.66 times in the retail segment
JFL Life Sciences IPO non-institutional investor subscription rate was 6.19 times in the non-institutional investor category
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 50% | 50% | - |
30 Aug 2022 (Day 4) | 11.66x | 6.19x | - |
29 Aug 2022 (Day 3) | 3.71x | 0.66x | - |
26 Aug 2022 (Day 2) | 1.65x | 0.51x | - |
25 Aug 2022 (Day 1) | 0.75x | 0.24x | - |
JFL Life Sciences FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from operations (Rs in millions) | Cash Flow from operations (Rs in millions) | Free Cash flow (Rs in millions) | Margins |
| 11MFY22 | 25.3 | 249.1 | 18.9 | 9.3 | 20.6% |
| FY21 | 5.4 | 327.7 | -58.7 | -75.9 | 6.9% |
| FY20 | 3.6 | 301.7 | 32.1 | 4.3 | 6.3% |
| FY19 | 3.0 | 317.8 | -30.0 | -36.1 | 4.2% |
JFL Life Sciences IPO SUBSCRIPTION STATUS DETAILS
JFL Life Sciences had 3.0 M shares on offer
JFL Life Sciences IPO offer price was ₹61
JFL Life Sciences IPO minimum Investment was ₹122000
JFL Life Sciences IPO issue size was ₹ 181.7 M
JFL Life Sciences had a minimum lot size of 2000 Shares per application
JFL Life Sciences NUMBER OF SHARES ON OFFER
JFL Life Sciences IPO IMPORTANT DATES
| Issue Open Date | 25 Aug 2022 |
| Issue close Date | 30 Aug 2022 |
| Allotment Date | 05 Sep 2022 |
| Refund Date | 06 Sep 2022 |
| Demat Account Credit Date | 07 Sep 2022 |
| Listing Date | 08 Sep 2022 |
| Listing on Exchange(s) | NSE |
| JFL Life Sciences Allotment Status | Exchange |
JFL Life Sciences IPO subscription opened on 25 Aug 2022, and closed on 30 Aug 2022
IPO allotment for JFL Life Sciences was finalized on Monday, 05 Sep 2022
IPO listing for JFL Life Sciences was on NSE on Thursday, 08 Sep 2022
JFL Life Sciences IPO LISTING GAINS
| Issue Price (adjusted) | 61.0 |
| Listing Open Price | 70.0 |
| Listing Close Price | 66.5 |
| Listing Gain% | 14.8% |
| Current Gain% | -78.4% |
JFL Life Sciences Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JFL Life Sciences Ltd. | 13.2 | 14.5 | 13.6 | 0.1 | 0.7 | 14 | 6 | 131.5 | 60.2 | 6.4 | 54 | 1 | 126.2 |
| Sun Pharmaceutical Industries Ltd. | 1942 | 465950.9 | 38.5 | 2.3 | 7.8 | 13.7 | 10.6 | 60433.8 | 10.8 | 11479.4 | 5 | 50.4 | 16.6 |
| Divi's Laboratories Ltd. | 8578.5 | 227732.2 | 77.9 | 2.9 | 20.3 | 15.3 | 12.8 | 11067 | 14 | 2568 | 17.2 | 110.2 | 26.8 |
| Torrent Pharmaceuticals Ltd. | 4886 | 185847.8 | 85.2 | 9.5 | 11.8 | 25.8 | 4.9 | 13886.2 | 20.3 | 2163.4 | 13.2 | 57.3 | 8.9 |
| Zydus Lifesciences Ltd. | 1191 | 119842.5 | 26.6 | -17.1 | 4.2 | 18.6 | 9.6 | 27657.9 | 17.6 | 5040 | 11.4 | 44.9 | -1.6 |
| Cipla Ltd. | 1463 | 118188.9 | 35.1 | -0.9 | 4.2 | 11.3 | 9.1 | 29044.6 | 2.2 | 3879.2 | -26.4 | 41.7 | -37.5 |
JFL Life Sciences INFORMATION ON IPO ISSUE
About JFL Life Sciences
JFL Life Sciences was incorporated on April 25, 2010. The company is engaged in the business of manufacturing of pharmaceutical products. The product portfolio consists of dry powder injections, tablets and capsules (solid oral dosage form) and oral rehydration solutions.
Object of the Issue
- Repayment of secured and unsecured loans
- Funding the working capital requirements of the company
- General corporate purposes
JFL Life Sciences - PROMOTERS
| Name |
|---|
| Smiral Ashwinkumar Patel |
| Tejal Smiral Patel |
JFL Life Sciences Lead Manager
GYR Capital Advisors Private Limited
info@gyrcapitaladvisors.com
JFL Life Sciences Registrar to the issue
Kfin Technologies
jfl.ipo@kfintech.com
JFL Life Sciences Strengths
Product registration
The Company has registered its products in various countries like the sovereign of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing of a particular product
Experienced management
The company has a seasoned management team with extensive knowledge of the pharmaceutical manufacturing sector
Quality and brand strength
The manufacturing facility is WHO GMP certified for good manufacturing practices issued by the Foods and Drug Control Administration
JFL Life Sciences Risks
Required to obtain licenses
The company is required to obtain licenses and approvals under several legislations
Instances of delays of certain forms
There have been instances of delays of certain forms which were required to be filed as per the reporting requirements under the Companies Act, 1956 and Companies Act, 2013
Dependent on few customers and suppliers
The company is dependent on few customers and is also dependent on few suppliers for raw materials
IPO FAQs
The promoters of the company are Smiral Ashwinkumar Patel and Tejal Smiral Patel.
The category allocation of qualified institutional buyers is 0.0%, the category allocation of non individual investors or high networth individuals is 50.0% and for retail investors it is 50.0%.
The price band of the IPO is Rs 61.0 - 61.0.
The IPO application opens on Aug 25, 2022 and closes on Aug 30, 2022.
The minimum lot size for the IPO is 2000. The maximum lot size for the IPO is 2000.
For all category investors, the minimum application amount for this IPO is Rs. 122,000.0, the maximum value for this IPO is Rs 122,000.0.
This IPO will be allotted on Sep 05, 2022.
The refund will be credited to your account on Sep 06, 2022.
The allotted shares will be credited to your demat on Sep 07, 2022.
JFL Life Sciences Ltd.’s shares listed on the stock exchanges on Sep 08, 2022.